Publications

Dwight Heron, MD, FACRO, FACR

Cykert S, Eng E, Manning MA, Robertson LB, Heron DE, Jones NS, Schaal JC, Lightfoot A, Zhou H, Yongue C, Gizlice Z. A Multi-faceted Intervention Aimed at Black-White Disparities in the Treatment of Early Stage Cancers: The ACCURE Pragmatic Quality Improvement trial. J Natl Med Assoc. 2019 Mar 27; doi: 10.1016/j.jnma.2019.03.001. PubMed PMID: 30928088.
Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, Dunlap NE, Zakem SJ, Hassanzadeh C, Marcrom S, Boggs DH, Isrow D, Vargo JA, Heron DE, Siddiqui F, Bonner JA, Beitler JJ, Yao M, Trotti AM, Riaz N, Multi-Institution Re-Irradiation (MIRI) Collaborative.. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Oral Oncol. 2019 Mar;9080-86. doi: 10.1016/j.oraloncology.2019.01.022. PubMed PMID: 30846182.
Kim C, Prabhu AV, Hansberry DR, Agarwal N, Heron DE, Beriwal S. Digital Era of Mobile Communications and Smartphones: A Novel Analysis of Patient Comprehension of Cancer-Related Information Available Through Mobile Applications. Cancer Invest. 2019;37(3):127-133. doi: 10.1080/07357907.2019.1572760. PubMed PMID: 30821518.
Cramer JD, Samant S, Heron DE, Ferris RL, Kim S. Impact of postoperative radiation therapy for deeply invasive oral cavity cancer upstaged to stage III. Head Neck. 2019 May;41(5):1178-1183. doi: 10.1002/hed.25498. PubMed PMID: 30773733.
Cykert S, Eng E, Walker P, Manning MA, Robertson LB, Arya R, Jones NS, Heron DE. A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers. Cancer Med. 2019 Mar;8(3):1095-1102. doi: 10.1002/cam4.2005. PubMed PMID: 30714689; PMCID: PMC6434214.
Sutera P, Kalash R, Clump DA, D'Ambrosio D, Mihai A, Burton SA, Heron DE. Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases. Adv Radiat Oncol. 2019 Jan-Mar;4(1):57-62. doi: 10.1016/j.adro.2018.09.001. PubMed PMID: 30706011; PMCID: PMC6349603.
Yan C, Huq MS, Heron DE, Beriwal S, Wynn RB. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning. Brachytherapy. 2019 May - Jun;18(3):338-347. doi: 10.1016/j.brachy.2018.12.004. PubMed PMID: 30655047.
Teo PT, Hwang MS, Shields WG, Kosterin P, Jang SY, Heron DE, Lalonde RJ, Huq MS. Application of TG-100 risk analysis methods to the acceptance testing and commissioning process of a Halcyon linear accelerator. Med Phys. 2019 Mar;46(3):1341-1354. doi: 10.1002/mp.13378. PubMed PMID: 30620406.
Rodríguez-Lopéz JL, Ling DC, Heron DE, Beriwal S. Lag Time Between Evidence and Guidelines: Can Clinical Pathways Bridge the Gap? J Oncol Pract. 2019 Mar;15(3):e195-e201. doi: 10.1200/JOP.18.00430. PubMed PMID: 30526227.
Randhawa S, Viqar A, Strother J, Prabhu AV, Xia F, Heron D, Beriwal S. How Do Patients Rate Their Radiation Oncologists in the Modern Era: An Analysis of Vitals.com. Cureus. 2018 Sep 17;10(9):e3312. doi: 10.7759/cureus.3312. PubMed PMID: 30473945; PMCID: PMC6248776.
Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, Heron DE, Grandis JR, Argiris A. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives. Cancer. 2018 Oct 1;124(19):3881-3889. doi: 10.1002/cncr.31651. PubMed PMID: 30291796; PMCID: PMC6521720.
Ling DC, Karukonda P, Smith RP, Heron DE, Beriwal S. Declining brachytherapy utilization for high-risk prostate cancer-Can clinical pathways reverse the trend? Brachytherapy. 2018 Nov - Dec;17(6):895-898. doi: 10.1016/j.brachy.2018.08.004. PubMed PMID: 30217434.
Sutera P, Clump DA, Kalash R, D'Ambrosio D, Mihai A, Wang H, Petro DP, Burton SA, Heron DE. Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):116-122. doi: 10.1016/j.ijrobp.2018.08.027. PubMed PMID: 30149056.
Patel AK, Ling DC, Richman AH, Champ CE, Huq MS, Heron DE, Beriwal S. Hypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities? Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):71-77. doi: 10.1016/j.ijrobp.2018.08.024. PubMed PMID: 30145393.
Sutera PA, Bernard ME, Wang H, Heron DE. Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma. Front Oncol. 2018;8282. doi: 10.3389/fonc.2018.00282. PubMed PMID: 30101127; PMCID: PMC6072866.
Sutera P, Kalash R, Flickinger J, Engh J, Heron DE. Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT. Am J Clin Oncol. 2019 Jan;42(1):27-35. doi: 10.1097/COC.0000000000000470. PubMed PMID: 29912004.
Kalash R, Glaser SM, Flickinger JC, Burton S, Heron DE, Gerszten PC, Engh JA, Amankulor NM, Vargo JA. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate? J Neurosurg Spine. 2018 Aug;29(2):220-225. doi: 10.3171/2017.12.SPINE17920. PubMed PMID: 29799334.
Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field. Pract Radiat Oncol. 2018 May - Jun;8(3):e117-e123. doi: 10.1016/j.prro.2017.11.011. PubMed PMID: 29724402.
Ling DC, Flickinger JC, Burton SA, Heron DE, Quinn AE, Bejjani GK, Engh JA, Gerszten PC, Amankulor NM, Vargo JA. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):602-609. doi: 10.1016/j.ijrobp.2018.02.035. PubMed PMID: 29678526.
Dohopolski MJ, Horne Z, Clump D, Burton SA, Heron DE. Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease. Cureus. 2018 Feb 7;10(2):e2167. doi: 10.7759/cureus.2167. PubMed PMID: 29644155; PMCID: PMC5889151.
Prabhu AV, Randhawa S, Clump D, Heron DE, Beriwal S. What Do Patients Think About Their Radiation Oncologists? An Assessment of Online Patient Reviews on Healthgrades. Cureus. 2018 Feb 6;10(2):e2165. doi: 10.7759/cureus.2165. PubMed PMID: 29644154; PMCID: PMC5889152.
Sutera P, Bernard ME, Wang H, Bahary N, Burton S, Zeh H, Heron DE. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. Front Oncol. 2018;852. doi: 10.3389/fonc.2018.00052. PubMed PMID: 29564223; PMCID: PMC5845878.
Chen KS, Glaser SM, Garda AE, Vargo JA, Saiful Huq M, Heron DE, Beriwal S. Utilizing clinical pathways and web-based conferences to improve quality of care in a large integrated network using breast cancer radiation therapy as the model. Radiat Oncol. 2018 Mar 16;13(1):44. doi: 10.1186/s13014-018-0995-0. PubMed PMID: 29548340; PMCID: PMC5857077.
Kim H, Vargo JA, Beriwal S, Clump DA, Ohr JP, Ferris RL, Heron DE, Huq MS, Smith KJ. Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer. Head Neck. 2018 Aug;40(8):1743-1751. doi: 10.1002/hed.25142. PubMed PMID: 29537684.
Kalash R, Pifer PM, Beriwal S, Glaser SM, Vargo JA, Heron DE. Exceptional Eight-year Response to Stereotactic Radiosurgery Monotherapy for Multiple Brain Metastases. Cureus. 2017 Dec 29;9(12):e2001. doi: 10.7759/cureus.2001. PubMed PMID: 29507849; PMCID: PMC5832406.
Vargo JA, Moiseenko V, Grimm J, Caudell J, Clump DA, Yorke E, Xue J, Vinogradskiy Y, Moros EG, Mavroidis P, Jain S, El Naqa I, Marks LB, Heron DE. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group. Int J Radiat Oncol Biol Phys. 2018 Jan 31; doi: 10.1016/j.ijrobp.2018.01.044. PubMed PMID: 29477291.
Caudell JJ, Ward MC, Riaz N, Zakem SJ, Awan MJ, Dunlap NE, Isrow D, Hassanzadeh C, Vargo JA, Heron DE, Marcrom S, Boggs DH, Reddy CA, Dault J, Bonner JA, Higgins KA, Beitler JJ, Koyfman SA, Machtay M, Yao M, Trotti AM, Siddiqui F, Lee NY, Multi-Institution Reirradiation (MIRI) Collaborative.. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):606-617. doi: 10.1016/j.ijrobp.2017.11.036. PubMed PMID: 29413274.
Gebhardt BJ, Vargo JA, Ling D, Jones B, Mohney M, Clump DA, Ohr JP, Ferris RL, Heron DE. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):195-200. doi: 10.1016/j.ijrobp.2017.11.045. PubMed PMID: 29398127.
Mihai A, Mu Y, Armstrong J, Dunne M, Beriwal S, Rock L, Thirion P, Heron DE, Bird BH, Westrup J, Murphy CG, Huq MS, McDermott R. Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease. J Radiosurg SBRT. 2017;5(1):43-53. PubMed PMID: 29296462; PMCID: PMC5675507.
Quan K, Sutera P, Xu K, Bernard ME, Burton SA, Wegner RE, Zeh H, Bahary N, Stoller R, Heron DE. Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma. Pract Radiat Oncol. 2018 Mar - Apr;8(2):95-106. doi: 10.1016/j.prro.2017.10.001. PubMed PMID: 29291966.
Horne ZD, Richman AH, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers. Lung Cancer. 2018 Jan;1151-4. doi: 10.1016/j.lungcan.2017.10.014. PubMed PMID: 29290248.
Glaser SM, Kalash R, Bongiorni DR, Roberts MS, Balasubramani GK, Jacobs BL, Beriwal S, Heron DE, Greenberger JS. Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer. In Vivo. 2018 Jan-Feb;32(1):113-120. doi: 10.21873/invivo.11212. PubMed PMID: 29275307; PMCID: PMC5892645.
Sutera PA, Bernard ME, Gill BS, Quan K, Engh JA, Burton SA, Heron DE. Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy. Future Oncol. 2017 Dec;13(29):2681-2690. doi: 10.2217/fon-2017-0226. PubMed PMID: 29198146.
Sutera PA, Bernard ME, Gill BS, Harper KK, Quan K, Bahary N, Burton SA, Zeh H, Heron DE. One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review. Front Oncol. 2017;7272. doi: 10.3389/fonc.2017.00272. PubMed PMID: 29184848; PMCID: PMC5694485.
Shayan G, Kansy BA, Gibson SP, Srivastava RM, Bryan JK, Bauman JE, Ohr J, Kim S, Duvvuri U, Clump DA, Heron DE, Johnson JT, Hershberg RM, Ferris RL. Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. Clin Cancer Res. 2018 Jan 1;24(1):62-72. doi: 10.1158/1078-0432.CCR-17-0357. PubMed PMID: 29061643; PMCID: PMC5754237.
Gogineni E, Vargo JA, Glaser SM, Flickinger JC, Burton SA, Engh JA, Amankulor NM, Beriwal S, Quinn AE, Ozhasoglu C, Heron DE. Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and Counseling. Neurosurgery. 2018 Aug 1;83(2):203-209. doi: 10.1093/neuros/nyx376. PubMed PMID: 28945873.
Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Ahrendt GM, Diego E, Heron DE, Beriwal S. Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network. Pract Radiat Oncol. 2018 Jan - Feb;8(1):4-12. doi: 10.1016/j.prro.2017.07.012. PubMed PMID: 28939351.
Prabhu AV, Kim C, De Guzman E, Zhao E, Madill E, Cohen J, Hansberry DR, Agarwal N, Heron DE, Beriwal S. Reputation Management and Content Control: An Analysis of Radiation Oncologists' Digital Identities. Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1083-1091. doi: 10.1016/j.ijrobp.2017.08.015. PubMed PMID: 28939228.
Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Hassanadeh C, Beitler JJ, Reddy CA, Marcrom S, Boggs DH, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Ferris RL, Heron DE. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):595-605. doi: 10.1016/j.ijrobp.2017.04.017. PubMed PMID: 28899556.
Karukonda P, Gebhardt BJ, Horne ZD, Heron DE, Beriwal S. Standardization of radiation therapy dose for locally advanced non-small cell lung cancer through changes to a lung cancer clinical pathway in a large, integrated comprehensive cancer center network. Pract Radiat Oncol. 2017 Nov - Dec;7(6):e551-e557. doi: 10.1016/j.prro.2017.07.003. PubMed PMID: 28867544.
Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Marcrom S, Boggs DH, Hassanzadeh C, Reddy CA, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Multi-Institution Reirradiation (MIRI) Collaborative.. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):586-594. doi: 10.1016/j.ijrobp.2017.06.012. PubMed PMID: 28865925.
Hepel JT, Heron DE, Mundt AJ, Yashar C, Feigenberg S, Koltis G, Regine WF, Prasad D, Patel S, Sharma N, Hebert M, Wallis N, Kuettel M. Comparison of Onsite Versus Online Chart Reviews as Part of the American College of Radiation Oncology Accreditation Program. J Oncol Pract. 2017 May;13(5):e516-e521. doi: 10.1200/JOP.2016.015230. PubMed PMID: 28301278.
Rwigema JM, Choi J, Lee NY, Heron DE, Chen AM. Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice Patterns. Cancer Invest. 2017 Jul 3;35(6):393-402. doi: 10.1080/07357907.2017.1310222. PubMed PMID: 28437131.
Gebhardt BJ, Ohr JP, Ferris RL, Duvvuri U, Kim S, Johnson JT, Heron DE, Clump DA 2nd. Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies. Am J Clin Oncol. 2018 Sep;41(9):888-893. doi: 10.1097/COC.0000000000000386. PubMed PMID: 28394767.
Prabhu AV, Crihalmeanu T, Hansberry DR, Agarwal N, Glaser C, Clump DA, Heron DE, Beriwal S. Online palliative care and oncology patient education resources through Google: Do they meet national health literacy recommendations? Pract Radiat Oncol. 2017 Sep - Oct;7(5):306-310. doi: 10.1016/j.prro.2017.01.013. PubMed PMID: 28341318.
Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Schroeck FR, Bekelman JE, Kahn JM, Nelson JB, Barnato AE. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer. Cancer. 2017 Aug 1;123(15):2945-2954. doi: 10.1002/cncr.30574. PubMed PMID: 28301689; PMCID: PMC5517344.
Zhang Y, Yang Y, Fu W, Li X, Li T, Heron DE, Huq MS. 4D VMAT planning and verification technique for dynamic tracking using a direct aperture deformation (DAD) method. J Appl Clin Med Phys. 2017 Mar;18(2):50-61. doi: 10.1002/acm2.12053. PubMed PMID: 28300367; PMCID: PMC5466079.
Gebhardt BJ, Heron DE, Beriwal S. A peer review process as part of the implementation of clinical pathways in radiation oncology: Does it improve compliance? Pract Radiat Oncol. 2017 Sep - Oct;7(5):332-338. doi: 10.1016/j.prro.2017.01.006. PubMed PMID: 28284760.
Holt DE, Bernard ME, Quan K, Clump DA, Engh JA, Burton SA, Heron DE. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy. J Cancer Res Ther. 2016 Oct-Dec;12(4):1243-1248. doi: 10.4103/0973-1482.199537. PubMed PMID: 28169234.
Bernard ME, Glaser SM, Gill BS, Beriwal S, Heron DE, Luketich JD, Friedland DM, Socinski MA, Greenberger JS. Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer. Front Oncol. 2017;71. doi: 10.3389/fonc.2017.00001. PubMed PMID: 28168163; PMCID: PMC5253386.
Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncol. 2017 Mar;13(7):603-613. doi: 10.2217/fon-2016-0403. PubMed PMID: 27842456.
Prabhu AV, Hansberry DR, Agarwal N, Clump DA, Heron DE. Radiation Oncology and Online Patient Education Materials: Deviating From NIH and AMA Recommendations. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):521-8. doi: 10.1016/j.ijrobp.2016.06.2449. PubMed PMID: 27681748.
Jang SY, Lalonde R, Ozhasoglu C, Burton S, Heron D, Huq MS. Dosimetric comparison between cone/Iris-based and InCise MLC-based CyberKnife plans for single and multiple brain metastases. J Appl Clin Med Phys. 2016 Sep 8;17(5):184-199. doi: 10.1120/jacmp.v17i5.6260. PubMed PMID: 27685124; PMCID: PMC5874093.
Albergotti WG, Davis KS, Abberbock S, Bauman JE, Ohr J, Clump DA, Heron DE, Duvvuri U, Kim S, Johnson JT, Ferris RL. Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma. Oral Oncol. 2016 Sep;6055-60. doi: 10.1016/j.oraloncology.2016.07.003. PubMed PMID: 27531873; PMCID: PMC4991628.
He S, Gill BS, Heron DE, Kelley JL, Sukumvanich P, Olawaiye AB, Edwards RP, Comerci J, Beriwal S. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma. Pract Radiat Oncol. 2017 Jan - Feb;7(1):19-25. doi: 10.1016/j.prro.2016.06.005. PubMed PMID: 27527897.
Ling DC, Vargo JA, Heron DE. Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Cancer J. 2016 Jul-Aug;22(4):302-6. doi: 10.1097/PPO.0000000000000208. PubMed PMID: 27441751.
Ling DC, Vargo JA, Ferris RL, Ohr J, Clump DA, Yau WW, Duvvuri U, Kim S, Johnson JT, Bauman JE, Branstetter BF, Heron DE. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):973-980. doi: 10.1016/j.ijrobp.2016.02.049. PubMed PMID: 27302512.
Wong SJ, Heron DE, Stenson K, Ling DC, Vargo JA. Locoregional Recurrent or Second Primary Head and Neck Cancer: Management Strategies and Challenges. Am Soc Clin Oncol Educ Book. 2016;35e284-92. doi: 10.1200/EDBK_157804. PubMed PMID: 27249734.
Horne ZD, Glaser SM, Vargo JA, Ferris RL, Balasubramani GK, Clump DA, Heron DE, Beriwal S. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Cancer. 2016 Jul 1;122(13):2021-30. doi: 10.1002/cncr.30021. PubMed PMID: 27111669.
Kent MS, Mandrekar SJ, Landreneau R, Nichols F, Foster NR, DiPetrillo TA, Meyers B, Heron DE, Jones DR, Tan AD, Starnes S, Putnam JB Jr, Fernando HC. A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032). Ann Thorac Surg. 2016 Jul;102(1):239-46. doi: 10.1016/j.athoracsur.2016.01.063. PubMed PMID: 27101729; PMCID: PMC4993046.
Kent MS, Mandrekar SJ, Landreneau R, Nichols F, DiPetrillo TA, Meyers B, Heron DE, Jones DR, Tan AD, Starnes S, Putnam JB Jr, Fernando HC. Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance). Ann Thorac Surg. 2016 Jul;102(1):230-8. doi: 10.1016/j.athoracsur.2016.01.069. PubMed PMID: 27101728; PMCID: PMC4993049.
Quan K, Xu KM, Zhang Y, Clump DA, Flickinger JC, Lalonde R, Burton SA, Heron DE. Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma. Semin Radiat Oncol. 2016 Apr;26(2):112-9. doi: 10.1016/j.semradonc.2015.11.007. PubMed PMID: 27000507.
Li T, Ozhasoglu C, Burton S, Flickinger J, Heron DE, Huq MS. A method to improve dose gradient for robotic radiosurgery. J Appl Clin Med Phys. 2015 Nov 8;16(6):333-339. doi: 10.1120/jacmp.v16i6.5748. PubMed PMID: 26699588; PMCID: PMC5690989.
Davis KS, Lim CM, Clump DA, Heron DE, Ohr JP, Kim S, Duvvuri U, Johnson JT, Ferris RL. Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer. Head Neck. 2016 Apr;38 Suppl 1E1613-7. doi: 10.1002/hed.24287. PubMed PMID: 26681273; PMCID: PMC4844840.
Chapman BV, Rajagopalan MS, Heron DE, Flickinger JC, Beriwal S. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):854-61. doi: 10.1016/j.ijrobp.2015.08.013. PubMed PMID: 26530754.
Quan K, Xu KM, Lalonde R, Horne ZD, Bernard ME, McCoy C, Clump DA, Burton SA, Heron DE. Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery. Front Oncol. 2015;5213. doi: 10.3389/fonc.2015.00213. PubMed PMID: 26500888; PMCID: PMC4594030.
Gebhardt BJ, Rajagopalan MS, Gill BS, Heron DE, Rakfal SM, Flickinger JC, Beriwal S. Impact of dynamic changes to a bone metastases pathway in a large, integrated, National Cancer Institute-designated comprehensive cancer center network. Pract Radiat Oncol. 2015 Nov-Dec;5(6):398-405. doi: 10.1016/j.prro.2015.06.013. PubMed PMID: 26432676.
Pennathur A, Luketich JD, Heron DE, Schuchert MJ, Bianco V, Clump D, Burton S, Abbas G, Gooding WE, Ozhasoglu C, Landreneau RJ, Christie NA. Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients. Ann Thorac Surg. 2015 Dec;100(6):2019-24. doi: 10.1016/j.athoracsur.2015.04.113. PubMed PMID: 26387725.
Gill BS, Clump DA, Burton SA, Christie NA, Schuchert MJ, Heron DE. Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy. Front Oncol. 2015;5109. doi: 10.3389/fonc.2015.00109. PubMed PMID: 26029665; PMCID: PMC4426786.
Holt DE, Gill BS, Clump DA, Leeman JE, Burton SA, Amankulor NM, Engh JA, Heron DE. Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis. Front Oncol. 2015;584. doi: 10.3389/fonc.2015.00084. PubMed PMID: 25905042; PMCID: PMC4389371.
Xu KM, Quan K, Clump DA, Ferris RL, Heron DE. Stereotactic ablative radiosurgery for locally advanced or recurrent skull base malignancies with prior external beam radiation therapy. Front Oncol. 2015;565. doi: 10.3389/fonc.2015.00065. PubMed PMID: 25853093; PMCID: PMC4362305.
Rajagopalan MS, Flickinger JC, Heron DE, Beriwal S. Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network. Pract Radiat Oncol. 2015 Mar-Apr;5(2):63-9. doi: 10.1016/j.prro.2014.10.004. PubMed PMID: 25748004.
Vargo JA, Ferris RL, Ohr J, Clump DA, Davis KS, Duvvuri U, Kim S, Johnson JT, Bauman JE, Gibson MK, Branstetter BF, Heron DE. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):480-8. doi: 10.1016/j.ijrobp.2014.11.023. PubMed PMID: 25680594.
Zhao B, Yang Y, Li X, Li T, Heron DE, Saiful Huq M. Is high-dose rate RapidArc-based radiosurgery dosimetrically advantageous for the treatment of intracranial tumors? Med Dosim. 2015 Spring;40(1):3-8. doi: 10.1016/j.meddos.2014.01.002. PubMed PMID: 25645205.
Rhieu BH, Rajagopalan MS, Sukumvanich P, Kelley JL, Ahrendt GM, Heron DE, Beriwal S. Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy. Pract Radiat Oncol. 2015 Jul-Aug;5(4):e267-73. doi: 10.1016/j.prro.2014.12.003. PubMed PMID: 25620165.

<< Investigators Search

Top